Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Neuropace
NPCE
$498M
| $1.87M | ﹤0.01% |
117,960
+6,980
| +6% | +$147K |
|
3377
Shore Bancshares
SHBI
$799M
| $1.87M | ﹤0.01% |
105,370
+1,766
| +2% | +$30.7K |
|
|
AKYA
3378
DELISTED
Akoya BioSciences
AKYA
| $1.87M | ﹤0.01% |
133,772
+8,074
| +6% | +$135K |
|
3379
Velocity Financial
VEL
$715M
| $1.86M | ﹤0.01% |
141,672
+1,103
| +0.8% | +$14.1K |
|
|
TLMD
3380
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
| $1.86M | ﹤0.01% |
825,155
-25,023
| -3% | -$89.9K |
|
|
GBL
3381
DELISTED
GAMCO Investors, Inc.
GBL
| $1.85M | ﹤0.01% |
70,281
-165
| -0.2% | -$4.4K |
|
3382
Biomea Fusion
BMEA
$92.8M
| $1.85M | ﹤0.01% |
154,722
+10,461
| +7% | +$133K |
|
|
WMC
3383
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $1.85M | ﹤0.01% |
70,977
+15,977
| +29% | +$455K |
|
3384
Ovid Therapeutics
OVID
$523M
| $1.85M | ﹤0.01% |
550,902
+100,378
| +22% | +$366K |
|
|
CMCT
3385
Creative Media & Community Trust
CMCT
$15M
| $1.85M | ﹤0.01% |
8
-3
| -27% | -$573K |
|
|
CKPT
3386
DELISTED
Checkpoint Therapeutics
CKPT
| $1.85M | ﹤0.01% |
55,996
+7,055
| +14% | +$209K |
|
3387
ARS Pharmaceuticals
SPRY
$606M
| $1.85M | ﹤0.01% |
185,112
-35,576
| -16% | -$877K |
|
|
CSPR
3388
DELISTED
Casper Sleep Inc.
CSPR
| $1.85M | ﹤0.01% |
432,546
-512
| -0.1% | -$3.06K |
|
3389
Timberland Bancorp
TSBK
$361M
| $1.84M | ﹤0.01% |
63,699
+482
| +0.8% | +$13.8K |
|
|
LSEA
3390
DELISTED
Landsea Homes
LSEA
| $1.84M | ﹤0.01% |
212,011
+35,006
| +20% | +$300K |
|
3391
AMES National
ATLO
$281M
| $1.83M | ﹤0.01% |
78,869
+543
| +0.7% | +$12.8K |
|
3392
Assembly Biosciences
ASMB
$594M
| $1.83M | ﹤0.01% |
43,772
+4,413
| +11% | +$185K |
|
|
CVLY
3393
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $1.83M | ﹤0.01% |
81,073
+3,369
| +4% | +$74K |
|
3394
InterContinental Hotels
IHG
$23.5B
| $1.82M | ﹤0.01% |
28,314
+19,685
| +228% | +$1.27M |
|
|
SMED
3395
DELISTED
Sharps Compliance Corp
SMED
| $1.82M | ﹤0.01% |
219,937
+196
| +0.1% | +$1.82K |
|
3396
Matinas BioPharma
MTNB
$1.49M
| $1.81M | ﹤0.01% |
27,895
+1,516
| +6% | +$65.4K |
|
3397
Innodata
INOD
$2.03B
| $1.81M | ﹤0.01% |
190,199
+10,113
| +6% | +$77.5K |
|
3398
First Business Financial Services
FBIZ
$601M
| $1.81M | ﹤0.01% |
62,971
+1,210
| +2% | +$33.4K |
|
3399
Rapid Micro Biosystems
RPID
$85.3M
| $1.8M | ﹤0.01% |
+97,756
| New | +$2.02M |
|
|
EEX
3400
DELISTED
Emerald Holding
EEX
| $1.8M | ﹤0.01% |
414,755
-11,674
| -3% | -$52.3K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.